MedPath
TGA Approval

DBL SODIUM ACETATE (ANHYDROUS) CONCENTRATED INJECTION 1.64g/10mL ampoule (16262)

16262

DBL SODIUM ACETATE (ANHYDROUS) CONCENTRATED INJECTION 1.64g/10mL ampoule

Pfizer Australia Pty Ltd

October 8, 1991

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01888-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01887-1

Active Ingredients

sodium acetate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DBL SODIUM ACETATE (ANHYDROUS) CONCENTRATED INJECTION 1.64g/10mL ampoule (16262) - TGA 批准文号 | MedPath